Ascendis Pharma A/S
Ticker: 1612042
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|
| INCOME | ||||
| Revenue | 339.29+37.6% | 246.60+56.0% | 158.05+56.6% | 100.95 |
| Total Income | 339.29+37.6% | 246.60+56.0% | 158.05+56.6% | 100.95 |
| EXPENSES | ||||
| Expenditure | 118.82-46.4% | 221.79+5.1% | 211.00+2.8% | 205.17 |
| Tax | 23.12+103.4% | -677.52-17697.9% | 3.85+263.2% | 1.06 |
| PROFIT | ||||
| PBT | 230.09+577.6% | -48.18-37.6% | -35.01+62.6% | -93.57 |
| Net Profit | 206.97-67.1% | 629.34+1719.5% | -38.86+58.9% | -94.63 |
| KEY METRICS | ||||
| OPM % | 64.98%+54.92pp | 10.06%+43.57pp | -33.50%+66.50pp | -100.00% |
| NPM % | 61.00%-39.00pp | 100.00%+124.58pp | -24.59%+69.15pp | -93.73% |
| EPS | 3.22-68.4% | 10.20+1693.8% | -0.64+59.5% | -1.58 |